Atlas Trials

Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma

Clinical trial NCT05790200 · UNKNOWN

Trial details

NCT number
NCT05790200
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2023-04-01
Primary completion
2025-09-22
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.